Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: an open-label, multicentre, randomised, phase 3 trial

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Open Label ◽

Phase 3 ◽

Haemopoietic Stem Cell ◽

Preparative Regimen ◽

Haemopoietic Stem Cell Transplantation ◽

Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial

The Lancet Haematology ◽

10.1016/s2352-3026(19)30157-7 ◽

2020 ◽

Vol 7 (1) ◽

pp. e28-e39 ◽

Cited By ~ 12

Author(s):

Dietrich Wilhelm Beelen ◽

Rudolf Trenschel ◽

Matthias Stelljes ◽

Christoph Groth ◽

Tamás Masszi ◽

...

Keyword(s):

Stem Cell ◽

Acute Myeloid Leukaemia ◽

Myelodysplastic Syndrome ◽

Older Patients ◽

Phase 3 ◽

Haemopoietic Stem Cell ◽

Conditioning Treatment ◽

Haemopoietic Stem Cell Transplantation ◽

Sorafenib maintenance in patients with FLT3-ITD acute myeloid leukaemia undergoing allogeneic haematopoietic stem-cell transplantation: an open-label, multicentre, randomised phase 3 trial

The Lancet Oncology ◽

10.1016/s1470-2045(20)30455-1 ◽

2020 ◽

Vol 21 (9) ◽

pp. 1201-1212 ◽

Cited By ~ 5

Author(s):

Li Xuan ◽

Yu Wang ◽

Fen Huang ◽

Zhiping Fan ◽

Yajing Xu ◽

...

Keyword(s):

Stem Cell ◽

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Cell Transplantation ◽

Haematopoietic Stem Cell Transplantation ◽

Haematopoietic Stem Cell ◽

Open Label ◽

Phase 3 ◽

Acute myeloid leukaemia relapsing after allogeneic haemopoietic stem cell transplantation: prognostic factors and impact of initial therapy of relapse

Internal Medicine Journal ◽

10.1111/imj.13522 ◽

2018 ◽

Vol 48 (3) ◽

pp. 276-285 ◽

Cited By ~ 6

Author(s):

Andrew B. M. Lim ◽

Cameron Curley ◽

Chun Y. Fong ◽

Ian Bilmon ◽

Ashanka Beligaswatte ◽

...

Keyword(s):

Stem Cell ◽

Prognostic Factors ◽

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Cell Transplantation ◽

Initial Therapy ◽

Haemopoietic Stem Cell ◽

Haemopoietic Stem Cell Transplantation ◽

Faculty Opinions recommendation of Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.719895279.793511926 ◽

2015 ◽

Cited By ~ 1

Author(s):

Andrew Gennery

Keyword(s):

Stem Cell ◽

Randomised Controlled Trial ◽

Haemopoietic Stem Cell Transplantation

Controlled Trial ◽

Open Label ◽

Phase 3 ◽

Haemopoietic Stem Cell ◽

Open Label Phase ◽

Randomised Controlled ◽

Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial

The Lancet ◽

10.1016/s0140-6736(11)61938-7 ◽

2012 ◽

Vol 379 (9823) ◽

pp. 1301-1309 ◽

Cited By ~ 185

Author(s):

Selim Corbacioglu ◽

Simone Cesaro ◽

Maura Faraci ◽

Dominique Valteau-Couanet ◽

Bernd Gruhn ◽

...

Keyword(s):

Stem Cell ◽

Randomised Controlled Trial ◽

Haemopoietic Stem Cell Transplantation

Controlled Trial ◽

Open Label ◽

Phase 3 ◽

Haemopoietic Stem Cell ◽

Open Label Phase ◽

Randomised Controlled ◽

Faculty Opinions recommendation of Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: a prospective, open-label randomised phase 3 trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717958906.793462914 ◽

2012 ◽

Author(s):

Nelson Chao

Keyword(s):

Complete Remission ◽

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Cell Transplantation ◽

Reduced Intensity Conditioning ◽

Open Label ◽

Phase 3 ◽

First Complete Remission ◽

Reduced Intensity ◽

Impact of pre-transplant serum ferritin on outcomes of patients with myelodysplastic syndromes or secondary acute myeloid leukaemia receiving reduced intensity conditioning allogeneic haematopoietic stem cell transplantation

Leukemia Research ◽

10.1016/j.leukres.2009.10.028 ◽

2010 ◽

Vol 34 (6) ◽

pp. 723-727 ◽

Cited By ~ 59

Author(s):

Z.Y. Lim ◽

V. Fiaccadori ◽

S. Gandhi ◽

J. Hayden ◽

M. Kenyon ◽

...

Keyword(s):

Stem Cell ◽

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Myelodysplastic Syndromes ◽

Haematopoietic Stem Cell Transplantation ◽

Haematopoietic Stem Cell ◽

Reduced Intensity Conditioning ◽

Reduced Intensity ◽

163: Clofarabine Pre-Conditioning Prior to Allogeneic Stem Cell Transplantation in High Risk Acute Myeloid Leukaemia (AML): A Well Tolerated Regimen with Both Full and Reduced Toxicity Schedules

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2007.12.172 ◽

2008 ◽

Vol 14 (2) ◽

pp. 61

Author(s):

D.S. Richardson ◽

C. Hurlock ◽

K. Hill ◽

J. Newman ◽

N. McKeag ◽

...

Keyword(s):

Stem Cell ◽

High Risk ◽

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Cell Transplantation ◽

Allogeneic Stem Cell Transplantation ◽

Reduced Toxicity ◽

Trends in patient outcome over the past two decades following allogeneic stem cell transplantation for acute myeloid leukaemia: anALWP/EBMTanalysis

Journal of Internal Medicine ◽

10.1111/joim.12854 ◽

2018 ◽

Vol 285 (4) ◽

pp. 407-418 ◽

Cited By ~ 8

Author(s):

J. Canaani ◽

E. Beohou ◽

M. Labopin ◽

A. Ghavamzadeh ◽

D. Beelen ◽

...

Keyword(s):

Patient Outcome ◽

Stem Cell ◽

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Cell Transplantation ◽

Allogeneic Stem Cell Transplantation ◽

The Past ◽

Allogeneic stem cell transplantation after reduced-intensity conditioning for acute myeloid leukaemia: impact of chronic graft-versus-host disease

Current Opinion in Oncology ◽

10.1097/01.cco.0000357474.66035.9b ◽

2009 ◽

Vol 21 (Suppl 1) ◽

pp. S35-S37 ◽

Cited By ~ 5

Author(s):

David Valcárcel ◽

Rodrigo Martino ◽

Jose L Piñana ◽

Jorge Sierra

Keyword(s):

Stem Cell ◽

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Graft Versus Host Disease ◽

Allogeneic Stem Cell Transplantation ◽

Reduced Intensity Conditioning ◽

Graft Versus Host ◽

Reduced Intensity ◽